ArticleAnnals of emergency medicine2025
Association of Early Noninvasive Cardiac Stress Testing With Acute Myocardial Infarction and Mortality.
Article in Annals of emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
STUDY
objectiveThe evaluation for suspected acute coronary syndrome is a common and high-risk presentation in emergency departments (EDs). After exclusion of acute myocardial infarction (MI), patients often undergo early (within 72 hours) noninvasive cardiac testing. We evaluated the association between early noninvasive testing and death/acute MI in ED patients suspected of acute coronary syndrome.
methodsWe used a retrospective cohort study design within the adult ED patient population (from October 2015 to December 2020) in whom MI was ruled out, belonging to a large integrated health care delivery system. Using data on history (H), electrocardiogram (E), age (A), risk factors (R), and troponin (T), we computed the HEART risk score. We stratified the cohort into low (score 0 to 3), intermediate (score 4 to 6), and high (score ≥7) risk and followed them up to 1-year after ED discharge. The association between noninvasive testing within 3 days of the ED visit and composite risk of death/acute MI within 1-year of discharge was evaluated by propensity score analysis.
resultsThe cohort included 174,917 patients (61% low risk [age 53; women 58%; noninvasive testing 5%], 36% intermediate risk [age 71; women 52%; noninvasive testing 18%], and 3% high risk [age 74, women 45%; noninvasive testing 23%]). The risk reduction in death/acute MI associated with early noninvasive testing was -1.54% (-1.95% to -1.12%) number needed to treat (NNT)=65; -4.93% (-5.66% to -4.20%) NNT=20, and -8.98% (95% confidence interval -11.32% to -6.64%) NNT=11; and, in the low, intermediate, and high-risk respectively.
conclusionEarly noninvasive testing was associated with reduced risk of 1-year death or acute MI across all risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.